AMERICAN VIETNAMESE BIOTECH INCORPORATION

American Vietnamese Biotech Incorporation

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E. Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
3,400 ^VND	-2.86%		+6.25%	-12.82%

06/05	American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/02	American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022

May 05, 2022 at 11:59 am IST

American Vietnamese Biotech Incorporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was VND 47,696.93 million compared to VND 25,767.98 million a year ago. Net income was VND 12,312.53 million compared to net loss of VND 327.68 million a year ago. Basic earnings per share from continuing operations was VND 135.

Latest news about American Vietnamese Biotech Incorporation

American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/23/30	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01/23/01	CI
An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation for VND 29.4 billion.	20/23/20	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023	05/23/05	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	02/23/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/22/04	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.	25/22/25	CI
American Vietnamese Biotech Incorporation agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.	06/21/06	CI
American Vietnamese Biotech Incorporation announced that it has received VND 379.62045 billion in funding from Lotus Investment Management Joint Stock Company and other investors	01/21/01	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	02/21/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	02/20/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2020	04/20/04	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	31/20/31	CI
An undisclosed buyer acquired 5.28% stake in American Vietnamese Biotech Incorporation from Nguyen Thi Hong Hai.	02/19/02	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	31/19/31	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	02/19/02	CI
An undisclosed buyer acquired 8.5% stake in American Vietnamese Biotech Incorporation from Le Anh Hoi.	03/19/03	CI
American Vietnamese Biotech Incorporation announced that it expects to receive VND 280 billion in funding	26/19/26	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2018	17/19/17	CI
American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2018	15/19/15	CI

Chart American Vietnamese Biotech Incorporation

Duration

Period

Chart American Vietnamese Biotech Incorporation

More charts

Company Profile

American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AMERICAN VIETNAMESE BIOTECH INCORPORATION	-12.82%	1.8Cr
ELI LILLY AND COMPANY	+29.98%	68TCr
NOVO NORDISK A/S	+30.34%	57TCr
JOHNSON & JOHNSON	-3.52%	36TCr
MERCK & CO., INC.	+18.59%	33TCr
ABBVIE INC.	+4.07%	28TCr
ASTRAZENECA PLC	+16.21%	24TCr
NOVARTIS AG	+9.66%	21TCr
ROCHE HOLDING AG	-6.83%	20TCr
AMGEN INC.	+7.09%	17TCr

Other Pharmaceuticals